Literature DB >> 2569279

Onset and duration of neuromuscular blockade following high-dose vecuronium administration.

B Ginsberg1, P S Glass, T Quill, D Shafron, K D Ossey.   

Abstract

To determine the onset time and duration of high doses of vecuronium, 40 ASA Physical Status 1 and 2 patients were randomly assigned to receive either 100, 200, 300, or 400 micrograms/kg of vecuronium bromide for muscle relaxation during elective general surgery. Neuromuscular blockade was continuously quantitated by recording the electromyographic response to stimulation of the ulnar nerve train-of-four. The rate of onset of neuromuscular blockade, endotracheal intubating conditions, duration of neuromuscular blockade, and hemodynamic effects of vecuronium at each dose were evaluated and compared. The time from vecuronium administration to complete abolition of twitch tension (T1 = 0%) decreased from 208 +/- 41 to 106 +/- 35 s as the vecuronium dose was increased from 100 to 400 micrograms/kg (P less than 0.01). Corresponding times to endotracheal intubation (T1 less than 20%) also decreased from 183 +/- 24 to 96 +/- 31 s with increasing doses (P less than 0.01). Recovery time (T1 = 25%) increased from 37 +/- 13 to 138 +/- 24 min with increasing doses (P less than 0.01). No significant hemodynamic differences between the four groups were observed. Endotracheal intubating conditions were good or excellent in all patients. High doses of vecuronium may, therefore, be a useful alternative to succinylcholine when a rapid onset of neuromuscular blockade is required.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569279     DOI: 10.1097/00000542-198908000-00006

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

1.  A kinetic-dynamic model to explain the relationship between high potency and slow onset time for neuromuscular blocking drugs.

Authors:  F Donati; C Meistelman
Journal:  J Pharmacokinet Biopharm       Date:  1991-10

2.  Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation.

Authors:  L S Bluestein; L W Stinson; R L Lennon; S N Quessy; R M Wilson
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

Review 3.  Anesthetic consideration for neurointerventional procedures.

Authors:  Kyung Woon Joung; Ku Hyun Yang; Won Jung Shin; Myung Hee Song; Kyungdon Ham; Seung Chul Jung; Deok Hee Lee; Dae Chul Suh
Journal:  Neurointervention       Date:  2014-09-03

Review 4.  Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

5.  Duration of action of supplemental doses of vecuronium is related to the duration after the initial dose.

Authors:  T Otagiri; M Narita; M Nishizawa; C Nishimura
Journal:  J Anesth       Date:  1992-04       Impact factor: 2.078

6.  Rapid tracheal intubation with atracurium: the timing principle.

Authors:  K F Koh; F G Chen
Journal:  Can J Anaesth       Date:  1994-08       Impact factor: 5.063

7.  Onset of vecuronium neuromuscular block is more rapid in patients undergoing caesarean section.

Authors:  A Baraka; S Jabbour; Z Tabboush; A Sibai; A Bijjani; K Karam
Journal:  Can J Anaesth       Date:  1992-02       Impact factor: 5.063

8.  Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.

Authors:  Y Salib; J Frossard; B Plaud; B Debaene; C Meistelman; F Donati
Journal:  Can J Anaesth       Date:  1994-10       Impact factor: 5.063

9.  Accelerated onset of vecuronium neuromuscular block with pulmonary arterial administration.

Authors:  H Iwasaki; M Igarashi; S Kawana; A Namiki
Journal:  Can J Anaesth       Date:  1994-12       Impact factor: 5.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.